Skip to main content

Table 1 GRADE quality assessment criteria

From: Efficacy of N-acetylcysteine plus pirfenidone in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis

Study design

Initial quality of a body of evidence

Quality of evidence

Lower if

Higher if

RCT

High

High

Risk of Bias

Large effect

Ā 

Moderate

-1 Serious

ā€‰+ā€‰1 Large

Ā 

low

-2 Very serious

ā€‰+ā€‰2 Very large

Ā 

Extremely low

Inconsistency

Dose response

Ā Ā 

-1 Serious

ā€‰+ā€‰Evidence of a gradient

Ā Ā 

-2 Very serious

All plausible residual confounding

Ā Ā 

Indirectness

ā€‰+ā€‰1 Would reduce a demonstrated effect

Ā Ā 

-1 Serious

ā€‰+ā€‰1 Would suggest a spurious effect if no effect was observed

Ā Ā 

-2 Very serious

Ā 
Ā Ā 

Publication bias

Ā 
Ā Ā 

-1 Likely

Ā 
Ā Ā 

-2 Very likely

Ā